400 related articles for article (PubMed ID: 24441526)
1. Treatment of Hodgkin lymphoma: a 50-year perspective.
Canellos GP; Rosenberg SA; Friedberg JW; Lister TA; Devita VT
J Clin Oncol; 2014 Jan; 32(3):163-8. PubMed ID: 24441526
[No Abstract] [Full Text] [Related]
2. [Treatment strategy of Hodgkin lymphoma].
Nagai H
Rinsho Ketsueki; 2014 Oct; 55(10):1941-51. PubMed ID: 25297759
[No Abstract] [Full Text] [Related]
3. Treatment of advanced stage Hodgkin lymphoma--it's all about risk-benefit.
Phipps C; Lee YS; Hwang W
Br J Haematol; 2012 Oct; 159(1):113-5. PubMed ID: 22823109
[No Abstract] [Full Text] [Related]
4. [Our experiences in treating patients with Hodgkin disease in the last decade].
Simon Z; Keresztes K; Miltényi Z; Ress Z; Váróczy L; Vadász G; Gergely L; Illés A
Orv Hetil; 2007 Apr; 148(15):675-82. PubMed ID: 17416575
[TBL] [Abstract][Full Text] [Related]
5. [Results of the treatment of lymphogranulomatosis].
Kholin AV
Ter Arkh; 1986; 58(2):143-7. PubMed ID: 2422774
[No Abstract] [Full Text] [Related]
6. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
Ann Oncol; 2001 Sep; 12(9):1213-4. PubMed ID: 11697828
[No Abstract] [Full Text] [Related]
7. Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades.
Koumarianou AA; Xiros N; Papageorgiou E; Pectasides D; Economopoulos T
Anticancer Res; 2007; 27(2):1191-7. PubMed ID: 17465262
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of advanced Hodgkin lymphoma].
Kreissl S; Borchmann P
Dtsch Med Wochenschr; 2013 Jun; 138(23):1212-4. PubMed ID: 23720173
[No Abstract] [Full Text] [Related]
9. [Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
Klastersky J
Rev Med Brux; 1982 Apr; 3(4):223-34. PubMed ID: 6178138
[No Abstract] [Full Text] [Related]
10. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy of malignant lymphomas].
Luporini G
Radiol Med; 1976; 62(7-8):553-7. PubMed ID: 95671
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of survival in Hodgkin's lymphoma.
Canellos GP; Niedzwiecki D; Johnson JL
N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
[No Abstract] [Full Text] [Related]
13. [Controversy regarding the treatment of Hodgkin's disease].
Balwierz W; Armata J
Pol Tyg Lek; 1989 Apr; 44(14):315-9. PubMed ID: 2482966
[No Abstract] [Full Text] [Related]
14. The cure of Hodgkin's disease with drugs.
DeVita VT; Hubbard SM; Moxley JH
Adv Intern Med; 1983; 28():277-302. PubMed ID: 6188346
[No Abstract] [Full Text] [Related]
15. Does interim PET increase the value of ABVD in advanced-stage Hodgkin lymphoma?
Gallamini A; Kostakoglu L
Ann Oncol; 2015 Jun; 26(6):1045-1047. PubMed ID: 26003616
[No Abstract] [Full Text] [Related]
16. [Role of response to first-line chemotherapy and of the primary lesion in Hodgkin lymphoma].
Datsenko PV; Pan'shin GA; Sotnikov VM; Ivashin AV; Gombolevskiĭ VA; Golub SV; Evstikheev ÉV
Vopr Onkol; 2012; 58(1):66-70. PubMed ID: 22629831
[TBL] [Abstract][Full Text] [Related]
17. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
Hentrich M; Berger M; Wyen C; Siehl J; Rockstroh JK; Müller M; Fätkenheuer G; Seidel E; Nickelsen M; Wolf T; Rieke A; Schürmann D; Schmidmaier R; Planker M; Alt J; Mosthaf F; Engert A; Arasteh K; Hoffmann C
J Clin Oncol; 2012 Nov; 30(33):4117-23. PubMed ID: 23045592
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for Hodgkin's disease.
Ekert H
N Engl J Med; 2003 Sep; 349(12):1186-7; author reply 1186-7. PubMed ID: 13679536
[No Abstract] [Full Text] [Related]
19. [Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis].
Filatova LV; Plotnikova AA; Gershanovich ML; Semiglazova TIu
Vopr Onkol; 2013; 59(2):59-65. PubMed ID: 23814851
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
Chisesi T; Bellei M; Luminari S; Montanini A; Marcheselli L; Levis A; Gobbi P; Vitolo U; Stelitano C; Pavone V; Merli F; Liberati M; Baldini L; Bordonaro R; Pesce EA; Federico M
J Clin Oncol; 2011 Nov; 29(32):4227-33. PubMed ID: 21990405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
